Selective laser trabeculoplasty for open angle glaucoma
Article Sidebar
Published:
Dec 29, 2017
Keywords:
selective laser trapeculoplasty, primary open galucoma, safety, efficacy
Main Article Content
Abstract
Selective laser trabeculoplasty (SLT) is an important treatment option in open angle glaucoma. It has been shown to be as effective as argon laser trabeculoplasty in primary open angle glaucoma while having an improved safety profile. Its use is also indicated for other subtypes of open angle glaucoma (OAG) such as pseudoexfoliation (PXE) and pigmentary glaucoma. In this review, we present the current literature on the role of SLT in treating OAG. The indications, duration of effect, repeatability, cost effectiveness and clinical effectiveness of SLT were reviewed. Available evidence comparing SLT with ALT and medical treatment are also presented. We also discuss the applicability of SLT for PXE, pigmentary glaucoma, normal tension glaucoma and advanced OAG. Lastly, the complications of SLT and areas of further research are discussed.
Downloads
Download data is not yet available.
Article Details
How to Cite
1.
Liput J, Tan W. Selective laser trabeculoplasty for open angle glaucoma. Ophthatherapy [Internet]. 2017Dec.29 [cited 2024Apr.27];4(4):199-0. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/579
Issue
Section
Articles
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright: © Medical Education sp. z o.o. License allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
1. Worthen D, Wickham M. Argon laser trabeculotomy. Transactions-American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology. 1973; 78(2): OP371-5.
2. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Archives of Ophthalmology. 1979; 97(2): 319-22.
3. de Moura R, Paranhos CA Jr., Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev. 2007; (4): CD003919.
4. Samples JR, Singh K, Lin SC et al. Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology. 2011; 118(11): 2296-302.
5. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Experimental Eye Research. 1995; 60(4): 359-71.
6. Latina MA, Sibayan SA, Shin DH et al. Q-switched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology. 1998; 105(11): 2082-90.
7. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001; 108(4): 773-9.
8. Alvarado JA, Katz LJ, Trivedi S et al. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Archives of Ophthalmology. 2010; 128(6): 731-7.
9. Bylsma SS, Samples JR, Acott TS et al. Trabecular cell division after argon laser trabeculoplasty. Archives of Ophthalmology. 1988; 106(4): 544-7.
10. Kagan DB, Gorfinkel NS, Hutnik CM. Mechanisms of selective laser trabeculoplasty: a review. Clinical & Experimental Ophthalmology. 2014; 42(7): 675-81.
11. Alvarado JA, Iguchi R, Martinez J et al. Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. American Journal of Ophthalmology. 2010; 150(2): 254-64.
12. Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. International Ophthalmology Clinics. 2004; 44(1): 93-103.
13. Kara N, Altan C, Satana B et al. Comparison of selective laser trabeculoplasty success in patients treated with either prostaglandin or timolol/dorzolamide fixed combination. Journal of Ocular Pharmacology and Therapeutics. 2011; 27(4): 339-42.
14. Ayala M, Chen E. The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment. Journal of Ocular Pharmacology and Therapeutics. 2012; 28(2): 118-22.
15. Goldenfeld M, Geyer O, Segev E et al. Selective laser trabeculoplasty in uncontrolled pseudoexfoliation glaucoma. Ophthalmic Surgery, Lasers and Imaging Retina. 2011; 42(5): 390-3.
16. Juzych MS, Chopra V, Banitt MR et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004; 111(10): 1853-9.
17. Damji KF, Shah KC, Rock WJ. Selective laser trabeculoplasty vargon laser trabeculoplasty: a prospective randomised clinical trial. British Journal of Ophthalmology. 1999; 83(6): 718-22.
18. Tojo N, Oka M, Miyakoshi A et al. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. Journal of Glaucoma. 2014; 23(8): e138-43.
19. Lee JW, Gangwani RA, Chan JC et al. Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty. Journal of Glaucoma. 2015; 24(1): 77-80.
20. Bozkurt E, Kara N, Yazici A et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. American Journal of Ophthalmology. 2011; 152(6): 976-81.e2.
21. Baykara M, Hamidi NA, Akova-Budak B et al. Early results of selective laser trabeculoplasty in patients resistant to deep sclerectomy. European Journal of Ophthalmology. 2014; 24(3): 371-4.
22. Töteberg-Harms M, Rhee DJ. Selective laser trabeculoplasty following failed combined phacoemulsification cataract extraction and ab interno trabeculectomy. American Journal of Ophthalmology. 2013; 156(5): 936-40.e2.
23. Alkin Z, Satana B, Ozkaya A et al. Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study. BioMed Research International. 2014; 2014.
24. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology. 2006; 90(3): 262-7.
25. Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Current Opinion in Ophthalmology. 2007; 18(2): 140-5.
26. Pisella P, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. British Journal of Ophthalmology. 2002; 86(4): 418-23.
27. Chawla A, McGalliard JN, Batterbury M. Use of eyedrops in glaucoma: how can we help to reduce non compliance? Acta Ophthalmologica. 2007; 85(4): 464.
28. Lichter PR, Musch DC, Gillespie BW et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108(11): 1943-53.
29. Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clinical Ophthalmology (Auckland, NZ). 2015; 9: 833.
30. Hong BK, Winer JC, Martone JF et al. Repeat selective laser trabeculoplasty. Journal of Glaucoma. 2009; 18(3): 180.
31. Polat J, Grantham L, Mitchel K et al. Repeatability of selective laser trabeculoplasty. British Journal of Ophthalmology. 2016; 100(10): 1437-41.
32. Khouri AS, Lari HB, Berezina TL et al. Long term efficacy of repeat selective laser trabeculoplasty. Journal of Ophthalmic & Vision Research. 2014; 9(4): 444.
33. Francis BA, Loewen N, Hong B et al. Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmology. 2016; 16(1): 128.
34. Avery N, Ang GS, Nicholas S, Wells A. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. International Ophthalmology. 2013; 33(5): 501-6.
35. Cantor LB, Katz LJ, Cheng JW et al. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Current Medical Research and Opinion. 2008; 24(10): 2905-18.
36. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2006; 41(4): 449-56.
37. Group GLTR, The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990; 97(11): 1403-13.
38. Group GLTR, The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study. 7. Results. American Journal of Ophthalmology. 1995; 120(6): 718-31.
39. Leske MC, Heijl A, Hyman L et al. Early manifest glaucoma trial. Ophthalmology. 1999; 106(11): 2144-53.
40. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000; 130: 429-40.
41. Wong MO, Lee JW, Chay BW et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Survey of Ophthalmology. 2015; 60(1): 36-50.
42. Martinez-de-la-Casa J, Garcia-Feijoo J, Castillo A et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004; 18(5): 498.
43. Damji KF, Bovell AM, Hodge WG et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. British Journal of Ophthalmology. 2006; 90(12): 1490-4.
44. Birt CM. Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2007; 42(5): 715-9.
45. Russo V, Barone A, Cosma A et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. European Journal of Ophthalmology. 2009; 19(3): 429.
46. Almeida ED, Moreira Pinto L, Brant Fernandes RA et al. Pattern of intraocular pressure reduction following laser trabeculoplasty in open-angle glaucoma patients: comparison between selective and nonselective treatment. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 933.
47. Liu Y, Birt CM. Argon versus selective laser trabeculoplasty in younger patients: 2-year results. Journal of Glaucoma. 2012; 21(2): 112-5.
48. Kent SS, Hutnik CM, Birt CM et al. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. Journal of Glaucoma. 2015; 24(5): 344-7.
49. Rosenfeld E, Shemesh G, Kurtz S. The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients. Clinical Ophthalmology (Auckland, NZ). 2012; 6: 1935.
50. Nagar M, Ogunyomade A, O’Brart DP et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. British Journal of Ophthalmology. 2005; 89(11): 1413-7.
51. Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. British Journal of Ophthalmology. 2009; 93(4): 497-501.
52. Katz LJ, Steinmanna WC, Kabir A et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. Journal of Glaucoma. 2012; 21(7): 460-68.
53. Lai JS, Chua J, Tham C et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clinical & Experimental Ophthalmology. 2004; 32(4): 368-72.
54. McIlraith I, Strasfeld M, Colev G et al. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. Journal of Glaucoma. 2006; 15(2): 124-30.
55. Best U, Domack H, Schmidt V. Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty – a controlled prospective clinical trial on 284 eyes. Klinische Monatsblatter fur Augenheilkunde. 2007; 224(3): 173-9.
56. Schlote T, Kynigopoulos M. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma. International Ophthalmology. 2016; 36(1): 55-61.
57. Brusini P, Filacorda S. Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. Journal of Glaucoma. 2006; 15(1): 40-6.
58. Law SK, Shih K, Tran DH et al. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. American Journal of Ophthalmology. 2009; 148(5): 685-95e1.
59. Suzuki R, Dickens CJ, Iwach AG et al. Long-term follow-up of initially successful trabeculectomy with 5 fluorouracil injections. Ophthalmology. 2002; 109(10): 1921-4.
60. Landers J, Sarkies N, Bourne R et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012; 119(4): 694-702.
61. Zhang H, Yang Y, Xu J et al. Selective laser trabeculoplasty in treating post-trabeculectomy advanced primary open-angle glaucoma. Experimental and Therapeutic Medicine. 2016; 11(3): 1090-4.
62. Lee JW, Liu CC, Chan JC et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clinical Ophthalmology (Auckland, NZ). 2014; 8: 1787.
63. Hodge W, Damji KF, Rock W et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post treatment: results from a randomised clinical trial. British Journal of Ophthalmology. 2005; 89(9): 1157-60.
64. Harasymowycz PJ, Papamatheakis DG, Latina M et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. American Journal of Ophthalmology. 2005; 139(6): 1110-3.
65. Lindegger DJ, Funk J, Jaggi G. Long-term effect of selective laser trabeculoplasty on intraocular pressure in pseudoexfoliation glaucoma. Klinische Monatsblätter für Augenheilkunde. 2015; 232(04): 405-8.
66. Ayala M, Chen E. Comparison of selective laser trabeculoplasty (SLT) in primary open angle glaucoma and pseudoexfoliation glaucoma. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 1469.
67. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 5.
68. Lee JW, Ho WL, Chan J et al. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmology. 2015; 15(1): 1.
69. Lee JW, Shum JJ, Chan JC et al. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine. 2015; 94(24): e984.
70. Keyser D, Belder D, De Groot V. Prospective study on the effect of selective laser trabeculoplasty in normal tension glaucoma. International Journal of Ophthalmology & Eye Science. 2016; S1:008: 36-41.
71. Lee JW, Fu L, Chan J et al. Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma. Medicine. 2014; 93(27): e238. https://doi.org/10.1097/MD.0000000000000238.
72. Ayala M. Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. Journal of Glaucoma. 2014; 23(9): 616-9.
73. De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. Journal of Glaucoma. 2017; 26(2): e22-9.
74. Song J. Complications of selective laser trabeculoplasty: a review. Clinical Ophthalmology (Auckland, NZ). 2016; 10: 137.
75. Koktekir BE, Gedik S, Bakbak B. Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty. Clinical & Experimental Ophthalmology. 2013; 41(3): 305-7.
76. Kim DY, Singh A. Severe iritis and choroidal effusion following selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina. 2008; 39(5): 409-11.
77. Rouhiainen HJ, Teräsvirta ME, Tuovinen EJ. Peripheral anterior synechiae formation after trabeculoplasty. Archives of Ophthalmology. 1988; 106(2): 189-91.
78. Shihadeh WA, Ritch R, Liebmann JM. Hyphema occurring during selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina. 2006; 37(5): 432-3.
79. Traverso CE, Greenidge KC, Spaeth GL. Formation of peripheral anterior synechiae following argon laser trabeculoplasty: a prospective study to determine relationship to position of laser burns. Archives of Ophthalmology. 1984; 102(6): 861-3.
80. Kitazawa Y, Shirato S, Yamamoto T et al. Argon Laser Trabeculoplasty. Variation of Methods and Immediate Complications in Second European Glaucoma Symposium, Helsinki, May 1984. Springer Netherlands 1985.
81. Wechsler D, Wechsler I. Cystoid macular oedema after selective laser trabeculoplasty. Eye. 2010; 24(6): 1113.
82. Ha JH, Bowling B, Chen SD. Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient. Clinical & Experimental Ophthalmology. 2014; 42(2): 200-1.
83. Wu Z, Huang J, Sadda S. Selective laser trabeculoplasty complicated by cystoid macular edema: report of two cases. Yănkē xuébào. 2016; 27(4): 193-7.
84. Klamann MK, Maier AK, Gonnermann J et al. Adverse effects and short-term results after selective laser trabeculoplasty. Journal of Glaucoma. 2014; 23(2): 105-8.
85. Ong K, Ong L, Ong LB. Corneal endothelial abnormalities after selective laser trabeculoplasty (SLT). Journal of Glaucoma. 2015; 24(4): 286-90.
86. White AJ, Mukherjee A, Hanspal I et al. Acute transient corneal endothelial changes following selective laser trabeculoplasty. Clinical & Experimental Ophthalmology. 2013; 41(5): 435-41.
87. Regina M, Bunya VY, Orlin SE et al. Corneal edema and haze after selective laser trabeculoplasty. Journal of Glaucoma. 2011; 20(5): 327-29.
88. Song J, Song A, Palmares T, Song M. Myopic Shift Following Selective Laser Trabeculoplasty: A Case Report. British Journal of Medicine & Medical Research. 2014; 4(4): 1008-13.
89. Moubayed SP, Hamid M, Choremis J et al. An unusual finding of corneal edema complicating selective laser trabeculoplasty. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2009; 44(3): 337-8.
90. Gazzard G, Konstantakopoulou E, Garway-Heath D et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2017. https://doi.org/10.1136/bjophthalmol-2017-310877.
91. Pillunat LE, Jungeman AGM, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clinical Ophthalmology (Auckland, NZ). 2017; 11: 1583.
2. Wise JB, Witter SL. Argon laser therapy for open-angle glaucoma: a pilot study. Archives of Ophthalmology. 1979; 97(2): 319-22.
3. de Moura R, Paranhos CA Jr., Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database Syst Rev. 2007; (4): CD003919.
4. Samples JR, Singh K, Lin SC et al. Laser trabeculoplasty for open-angle glaucoma: a report by the american academy of ophthalmology. Ophthalmology. 2011; 118(11): 2296-302.
5. Latina MA, Park C. Selective targeting of trabecular meshwork cells: in vitro studies of pulsed and CW laser interactions. Experimental Eye Research. 1995; 60(4): 359-71.
6. Latina MA, Sibayan SA, Shin DH et al. Q-switched 532-nm Nd: YAG laser trabeculoplasty (selective laser trabeculoplasty): A multicenter, pilot, clinical study. Ophthalmology. 1998; 105(11): 2082-90.
7. Kramer TR, Noecker RJ. Comparison of the morphologic changes after selective laser trabeculoplasty and argon laser trabeculoplasty in human eye bank eyes. Ophthalmology. 2001; 108(4): 773-9.
8. Alvarado JA, Katz LJ, Trivedi S et al. Monocyte modulation of aqueous outflow and recruitment to the trabecular meshwork following selective laser trabeculoplasty. Archives of Ophthalmology. 2010; 128(6): 731-7.
9. Bylsma SS, Samples JR, Acott TS et al. Trabecular cell division after argon laser trabeculoplasty. Archives of Ophthalmology. 1988; 106(4): 544-7.
10. Kagan DB, Gorfinkel NS, Hutnik CM. Mechanisms of selective laser trabeculoplasty: a review. Clinical & Experimental Ophthalmology. 2014; 42(7): 675-81.
11. Alvarado JA, Iguchi R, Martinez J et al. Similar effects of selective laser trabeculoplasty and prostaglandin analogs on the permeability of cultured Schlemm canal cells. American Journal of Ophthalmology. 2010; 150(2): 254-64.
12. Latina MA, Gulati V. Selective laser trabeculoplasty: stimulating the meshwork to mend its ways. International Ophthalmology Clinics. 2004; 44(1): 93-103.
13. Kara N, Altan C, Satana B et al. Comparison of selective laser trabeculoplasty success in patients treated with either prostaglandin or timolol/dorzolamide fixed combination. Journal of Ocular Pharmacology and Therapeutics. 2011; 27(4): 339-42.
14. Ayala M, Chen E. The influence of topical prostaglandin analogues in inflammation after selective laser trabeculoplasty treatment. Journal of Ocular Pharmacology and Therapeutics. 2012; 28(2): 118-22.
15. Goldenfeld M, Geyer O, Segev E et al. Selective laser trabeculoplasty in uncontrolled pseudoexfoliation glaucoma. Ophthalmic Surgery, Lasers and Imaging Retina. 2011; 42(5): 390-3.
16. Juzych MS, Chopra V, Banitt MR et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004; 111(10): 1853-9.
17. Damji KF, Shah KC, Rock WJ. Selective laser trabeculoplasty vargon laser trabeculoplasty: a prospective randomised clinical trial. British Journal of Ophthalmology. 1999; 83(6): 718-22.
18. Tojo N, Oka M, Miyakoshi A et al. Comparison of fluctuations of intraocular pressure before and after selective laser trabeculoplasty in normal-tension glaucoma patients. Journal of Glaucoma. 2014; 23(8): e138-43.
19. Lee JW, Gangwani RA, Chan JC et al. Prospective study on the efficacy of treating normal tension glaucoma with a single session of selective laser trabeculoplasty. Journal of Glaucoma. 2015; 24(1): 77-80.
20. Bozkurt E, Kara N, Yazici A et al. Prophylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injection. American Journal of Ophthalmology. 2011; 152(6): 976-81.e2.
21. Baykara M, Hamidi NA, Akova-Budak B et al. Early results of selective laser trabeculoplasty in patients resistant to deep sclerectomy. European Journal of Ophthalmology. 2014; 24(3): 371-4.
22. Töteberg-Harms M, Rhee DJ. Selective laser trabeculoplasty following failed combined phacoemulsification cataract extraction and ab interno trabeculectomy. American Journal of Ophthalmology. 2013; 156(5): 936-40.e2.
23. Alkin Z, Satana B, Ozkaya A et al. Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study. BioMed Research International. 2014; 2014.
24. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology. 2006; 90(3): 262-7.
25. Stein JD, Challa P. Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty. Current Opinion in Ophthalmology. 2007; 18(2): 140-5.
26. Pisella P, Pouliquen P, Baudouin C. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication. British Journal of Ophthalmology. 2002; 86(4): 418-23.
27. Chawla A, McGalliard JN, Batterbury M. Use of eyedrops in glaucoma: how can we help to reduce non compliance? Acta Ophthalmologica. 2007; 85(4): 464.
28. Lichter PR, Musch DC, Gillespie BW et al. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001; 108(11): 1943-53.
29. Leahy KE, White AJ. Selective laser trabeculoplasty: current perspectives. Clinical Ophthalmology (Auckland, NZ). 2015; 9: 833.
30. Hong BK, Winer JC, Martone JF et al. Repeat selective laser trabeculoplasty. Journal of Glaucoma. 2009; 18(3): 180.
31. Polat J, Grantham L, Mitchel K et al. Repeatability of selective laser trabeculoplasty. British Journal of Ophthalmology. 2016; 100(10): 1437-41.
32. Khouri AS, Lari HB, Berezina TL et al. Long term efficacy of repeat selective laser trabeculoplasty. Journal of Ophthalmic & Vision Research. 2014; 9(4): 444.
33. Francis BA, Loewen N, Hong B et al. Repeatability of selective laser trabeculoplasty for open-angle glaucoma. BMC Ophthalmology. 2016; 16(1): 128.
34. Avery N, Ang GS, Nicholas S, Wells A. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. International Ophthalmology. 2013; 33(5): 501-6.
35. Cantor LB, Katz LJ, Cheng JW et al. Economic evaluation of medication, laser trabeculoplasty and filtering surgeries in treating patients with glaucoma in the US. Current Medical Research and Opinion. 2008; 24(10): 2905-18.
36. Lee R, Hutnik CM. Projected cost comparison of selective laser trabeculoplasty versus glaucoma medication in the Ontario Health Insurance Plan. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2006; 41(4): 449-56.
37. Group GLTR, The Glaucoma Laser Trial (GLT). 2. Results of argon laser trabeculoplasty versus topical medicines. Ophthalmology. 1990; 97(11): 1403-13.
38. Group GLTR, The Glaucoma Laser Trial (GLT) and glaucoma laser trial follow-up study. 7. Results. American Journal of Ophthalmology. 1995; 120(6): 718-31.
39. Leske MC, Heijl A, Hyman L et al. Early manifest glaucoma trial. Ophthalmology. 1999; 106(11): 2144-53.
40. The Advanced Glaucoma Intervention Study (AGIS). 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000; 130: 429-40.
41. Wong MO, Lee JW, Chay BW et al. Systematic review and meta-analysis on the efficacy of selective laser trabeculoplasty in open-angle glaucoma. Survey of Ophthalmology. 2015; 60(1): 36-50.
42. Martinez-de-la-Casa J, Garcia-Feijoo J, Castillo A et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004; 18(5): 498.
43. Damji KF, Bovell AM, Hodge WG et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. British Journal of Ophthalmology. 2006; 90(12): 1490-4.
44. Birt CM. Selective laser trabeculoplasty retreatment after prior argon laser trabeculoplasty: 1-year results. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2007; 42(5): 715-9.
45. Russo V, Barone A, Cosma A et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with uncontrolled open-angle glaucoma. European Journal of Ophthalmology. 2009; 19(3): 429.
46. Almeida ED, Moreira Pinto L, Brant Fernandes RA et al. Pattern of intraocular pressure reduction following laser trabeculoplasty in open-angle glaucoma patients: comparison between selective and nonselective treatment. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 933.
47. Liu Y, Birt CM. Argon versus selective laser trabeculoplasty in younger patients: 2-year results. Journal of Glaucoma. 2012; 21(2): 112-5.
48. Kent SS, Hutnik CM, Birt CM et al. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. Journal of Glaucoma. 2015; 24(5): 344-7.
49. Rosenfeld E, Shemesh G, Kurtz S. The efficacy of selective laser trabeculoplasty versus argon laser trabeculoplasty in pseudophakic glaucoma patients. Clinical Ophthalmology (Auckland, NZ). 2012; 6: 1935.
50. Nagar M, Ogunyomade A, O’Brart DP et al. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. British Journal of Ophthalmology. 2005; 89(11): 1413-7.
51. Nagar M, Luhishi E, Shah N. Intraocular pressure control and fluctuation: the effect of treatment with selective laser trabeculoplasty. British Journal of Ophthalmology. 2009; 93(4): 497-501.
52. Katz LJ, Steinmanna WC, Kabir A et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. Journal of Glaucoma. 2012; 21(7): 460-68.
53. Lai JS, Chua J, Tham C et al. Five-year follow up of selective laser trabeculoplasty in Chinese eyes. Clinical & Experimental Ophthalmology. 2004; 32(4): 368-72.
54. McIlraith I, Strasfeld M, Colev G et al. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. Journal of Glaucoma. 2006; 15(2): 124-30.
55. Best U, Domack H, Schmidt V. Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty – a controlled prospective clinical trial on 284 eyes. Klinische Monatsblatter fur Augenheilkunde. 2007; 224(3): 173-9.
56. Schlote T, Kynigopoulos M. Selective laser trabeculoplasty (SLT): 1-year results in early and advanced open angle glaucoma. International Ophthalmology. 2016; 36(1): 55-61.
57. Brusini P, Filacorda S. Enhanced Glaucoma Staging System (GSS 2) for classifying functional damage in glaucoma. Journal of Glaucoma. 2006; 15(1): 40-6.
58. Law SK, Shih K, Tran DH et al. Long-term outcomes of repeat vs initial trabeculectomy in open-angle glaucoma. American Journal of Ophthalmology. 2009; 148(5): 685-95e1.
59. Suzuki R, Dickens CJ, Iwach AG et al. Long-term follow-up of initially successful trabeculectomy with 5 fluorouracil injections. Ophthalmology. 2002; 109(10): 1921-4.
60. Landers J, Sarkies N, Bourne R et al. A twenty-year follow-up study of trabeculectomy: risk factors and outcomes. Ophthalmology. 2012; 119(4): 694-702.
61. Zhang H, Yang Y, Xu J et al. Selective laser trabeculoplasty in treating post-trabeculectomy advanced primary open-angle glaucoma. Experimental and Therapeutic Medicine. 2016; 11(3): 1090-4.
62. Lee JW, Liu CC, Chan JC et al. Predictors of success in selective laser trabeculoplasty for primary open angle glaucoma in Chinese. Clinical Ophthalmology (Auckland, NZ). 2014; 8: 1787.
63. Hodge W, Damji KF, Rock W et al. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post treatment: results from a randomised clinical trial. British Journal of Ophthalmology. 2005; 89(9): 1157-60.
64. Harasymowycz PJ, Papamatheakis DG, Latina M et al. Selective laser trabeculoplasty (SLT) complicated by intraocular pressure elevation in eyes with heavily pigmented trabecular meshworks. American Journal of Ophthalmology. 2005; 139(6): 1110-3.
65. Lindegger DJ, Funk J, Jaggi G. Long-term effect of selective laser trabeculoplasty on intraocular pressure in pseudoexfoliation glaucoma. Klinische Monatsblätter für Augenheilkunde. 2015; 232(04): 405-8.
66. Ayala M, Chen E. Comparison of selective laser trabeculoplasty (SLT) in primary open angle glaucoma and pseudoexfoliation glaucoma. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 1469.
67. Shazly TA, Smith J, Latina MA. Long-term safety and efficacy of selective laser trabeculoplasty as primary therapy for the treatment of pseudoexfoliation glaucoma compared with primary open-angle glaucoma. Clinical Ophthalmology (Auckland, NZ). 2011; 5: 5.
68. Lee JW, Ho WL, Chan J et al. Efficacy of selective laser trabeculoplasty for normal tension glaucoma: 1 year results. BMC Ophthalmology. 2015; 15(1): 1.
69. Lee JW, Shum JJ, Chan JC et al. Two-year clinical results after selective laser trabeculoplasty for normal tension glaucoma. Medicine. 2015; 94(24): e984.
70. Keyser D, Belder D, De Groot V. Prospective study on the effect of selective laser trabeculoplasty in normal tension glaucoma. International Journal of Ophthalmology & Eye Science. 2016; S1:008: 36-41.
71. Lee JW, Fu L, Chan J et al. Twenty-four-hour intraocular pressure related changes following adjuvant selective laser trabeculoplasty for normal tension glaucoma. Medicine. 2014; 93(27): e238. https://doi.org/10.1097/MD.0000000000000238.
72. Ayala M. Long-term outcomes of selective laser trabeculoplasty (SLT) treatment in pigmentary glaucoma patients. Journal of Glaucoma. 2014; 23(9): 616-9.
73. De Keyser M, De Belder M, De Groot V. Randomized prospective study of the use of anti-inflammatory drops after selective laser trabeculoplasty. Journal of Glaucoma. 2017; 26(2): e22-9.
74. Song J. Complications of selective laser trabeculoplasty: a review. Clinical Ophthalmology (Auckland, NZ). 2016; 10: 137.
75. Koktekir BE, Gedik S, Bakbak B. Bilateral severe anterior uveitis after unilateral selective laser trabeculoplasty. Clinical & Experimental Ophthalmology. 2013; 41(3): 305-7.
76. Kim DY, Singh A. Severe iritis and choroidal effusion following selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina. 2008; 39(5): 409-11.
77. Rouhiainen HJ, Teräsvirta ME, Tuovinen EJ. Peripheral anterior synechiae formation after trabeculoplasty. Archives of Ophthalmology. 1988; 106(2): 189-91.
78. Shihadeh WA, Ritch R, Liebmann JM. Hyphema occurring during selective laser trabeculoplasty. Ophthalmic Surgery, Lasers and Imaging Retina. 2006; 37(5): 432-3.
79. Traverso CE, Greenidge KC, Spaeth GL. Formation of peripheral anterior synechiae following argon laser trabeculoplasty: a prospective study to determine relationship to position of laser burns. Archives of Ophthalmology. 1984; 102(6): 861-3.
80. Kitazawa Y, Shirato S, Yamamoto T et al. Argon Laser Trabeculoplasty. Variation of Methods and Immediate Complications in Second European Glaucoma Symposium, Helsinki, May 1984. Springer Netherlands 1985.
81. Wechsler D, Wechsler I. Cystoid macular oedema after selective laser trabeculoplasty. Eye. 2010; 24(6): 1113.
82. Ha JH, Bowling B, Chen SD. Cystoid macular oedema following selective laser trabeculoplasty in a diabetic patient. Clinical & Experimental Ophthalmology. 2014; 42(2): 200-1.
83. Wu Z, Huang J, Sadda S. Selective laser trabeculoplasty complicated by cystoid macular edema: report of two cases. Yănkē xuébào. 2016; 27(4): 193-7.
84. Klamann MK, Maier AK, Gonnermann J et al. Adverse effects and short-term results after selective laser trabeculoplasty. Journal of Glaucoma. 2014; 23(2): 105-8.
85. Ong K, Ong L, Ong LB. Corneal endothelial abnormalities after selective laser trabeculoplasty (SLT). Journal of Glaucoma. 2015; 24(4): 286-90.
86. White AJ, Mukherjee A, Hanspal I et al. Acute transient corneal endothelial changes following selective laser trabeculoplasty. Clinical & Experimental Ophthalmology. 2013; 41(5): 435-41.
87. Regina M, Bunya VY, Orlin SE et al. Corneal edema and haze after selective laser trabeculoplasty. Journal of Glaucoma. 2011; 20(5): 327-29.
88. Song J, Song A, Palmares T, Song M. Myopic Shift Following Selective Laser Trabeculoplasty: A Case Report. British Journal of Medicine & Medical Research. 2014; 4(4): 1008-13.
89. Moubayed SP, Hamid M, Choremis J et al. An unusual finding of corneal edema complicating selective laser trabeculoplasty. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie. 2009; 44(3): 337-8.
90. Gazzard G, Konstantakopoulou E, Garway-Heath D et al. Laser in Glaucoma and Ocular Hypertension (LiGHT) Trial. A multicentre, randomised controlled trial: design and methodology. Br J Ophthalmol. 2017. https://doi.org/10.1136/bjophthalmol-2017-310877.
91. Pillunat LE, Jungeman AGM, Kimmich F. Micro-invasive glaucoma surgery (MIGS): a review of surgical procedures using stents. Clinical Ophthalmology (Auckland, NZ). 2017; 11: 1583.